Trends in Automated Peritoneal Dialysis Prescriptions in a Large Dialysis Organization in the United States.


Journal

Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570

Informations de publication

Date de publication:
19 Feb 2024
Historique:
received: 08 09 2023
accepted: 06 02 2024
medline: 19 2 2024
pubmed: 19 2 2024
entrez: 19 2 2024
Statut: aheadofprint

Résumé

Changes in health care policies and recognition of patient benefit have contributed to increases in home-based dialysis, including peritoneal dialysis (PD). Frequent monitoring and early individualization of PD prescriptions are key prerequisites for the delivery of high-quality PD. The present analysis aimed to assess variations in PD prescriptions among incident automated PD (APD) patients who remain on PD for 120+ days. This retrospective analysis examined data from patients within a large dialysis organization that initiated PD with APD between 2015 and 2019. PD prescription data was described by calendar year, timing of PD, and residual renal function categories. Changes in prescriptions from PD initiation (day 1) to day 120 were assessed descriptively. The cohort included 11,659 patients. The mean age at PD initiation increased from 2015 (56 (15) years) through 2019 (58 (15) years), whereas most other variables demonstrated no clear temporal change. Most patients (86%) had nighttime PD prescribed, with an average of 4.9 (1.3) cycles per day, a mean total treatment volume of 9.3 (2.5) L, and a median daily total dwell time of 7 (6,9.5) hours. Relative to day 1 nighttime prescriptions, there were 1) small increases in the proportion of patients receiving 3 or fewer cycles per day and those receiving 6+ cycles per day, 2) a 100 ml mean increase in fill volume per exchange, and 3) a mean 0.5 L increase in total nighttime treatment volume at day 120. When changes in nighttime APD prescriptions were examined at the patient level, 49% of patients had day 120 prescriptions that were unchanged from their initial prescription. In the largest analysis of incident APD prescriptions conducted in the United States to date, the vast majority of patients were prescribed nocturnal PD only with limited variability across the first 4 months of therapy.

Sections du résumé

BACKGROUND BACKGROUND
Changes in health care policies and recognition of patient benefit have contributed to increases in home-based dialysis, including peritoneal dialysis (PD). Frequent monitoring and early individualization of PD prescriptions are key prerequisites for the delivery of high-quality PD. The present analysis aimed to assess variations in PD prescriptions among incident automated PD (APD) patients who remain on PD for 120+ days.
METHODS METHODS
This retrospective analysis examined data from patients within a large dialysis organization that initiated PD with APD between 2015 and 2019. PD prescription data was described by calendar year, timing of PD, and residual renal function categories. Changes in prescriptions from PD initiation (day 1) to day 120 were assessed descriptively.
RESULTS RESULTS
The cohort included 11,659 patients. The mean age at PD initiation increased from 2015 (56 (15) years) through 2019 (58 (15) years), whereas most other variables demonstrated no clear temporal change. Most patients (86%) had nighttime PD prescribed, with an average of 4.9 (1.3) cycles per day, a mean total treatment volume of 9.3 (2.5) L, and a median daily total dwell time of 7 (6,9.5) hours. Relative to day 1 nighttime prescriptions, there were 1) small increases in the proportion of patients receiving 3 or fewer cycles per day and those receiving 6+ cycles per day, 2) a 100 ml mean increase in fill volume per exchange, and 3) a mean 0.5 L increase in total nighttime treatment volume at day 120. When changes in nighttime APD prescriptions were examined at the patient level, 49% of patients had day 120 prescriptions that were unchanged from their initial prescription.
CONCLUSIONS CONCLUSIONS
In the largest analysis of incident APD prescriptions conducted in the United States to date, the vast majority of patients were prescribed nocturnal PD only with limited variability across the first 4 months of therapy.

Identifiants

pubmed: 38373051
doi: 10.2215/CJN.0000000000000436
pii: 01277230-990000000-00357
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fresenius Medical Care North America

Informations de copyright

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology.

Auteurs

Harold E Giles (HE)

Nephrology Associates PC, Birmingham, Alabama.
Fresenius Medical Care Birmingham Home Clinic, Birmingham, Alabama.

Vidhya Parameswaran (V)

Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.

Rachel Lasky (R)

Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.

Linda Ficociello (L)

Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.

Claudy Mullon (C)

Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.

Dinesh K Chatoth (DK)

Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.

Michael Kraus (M)

Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.

Michael S Anger (MS)

Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.

Classifications MeSH